Calcium: A critical mineral for health and vitality

pharmanewsdaily- January 18, 2025 0

Calcium plays an indispensable role in maintaining the structural integrity and overall functionality of the human body. While commonly associated with bone and teeth health, ... Read More

How to strengthen your bones and prevent osteoporosis

pharmanewsdaily- December 24, 2024 0

Osteoporosis, a condition where bones become brittle and fragile due to a loss of bone mass, is a growing concern as people age. The balance ... Read More

Zydus Lifesciences’ Menostar Transdermal System generic gets FDA final approval

Pallavi Madhiraju- April 19, 2023 0

Zydus Lifesciences has secured final approval from the UA Food and Drug Administration (FDA) for Estradiol Transdermal System USP, 0.014 mg/day. The approved product which ... Read More

Biocon Biologics signs licensing deal for two biosimilars with Yoshindo

Pallavi Madhiraju- October 17, 2022 0

Biocon Ltd. said that its subsidiary Biocon Biologics has signed an out-licensing agreement with Japanese pharma company Yoshindo Inc. for commercializing a couple of its ... Read More

Haoma Medica completes first-in-human trial of NaQuinate, a promising osteoporosis treatment

pharmanewsdaily- November 28, 2020 0

Haoma Medica, a UK-based biotechnology company, has successfully wrapped up the first-in-human clinical trial of NaQuinate, a novel oral treatment designed to address osteoporosis. This ... Read More

Amgen and UCB resubmit BLA for EVENITY to transform osteoporosis treatment in postmenopausal women

pharmanewsdaily- July 15, 2018 0

Amgen, in collaboration with UCB, has announced the resubmission of the biologics license application (BLA) for their osteoporosis drug candidate, EVENITY (romosozumab), to the US ... Read More